M&G Investments: Investment Portfolio & Startup News

M&G Investments

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology

10 Jan 2026

bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology

bit.bio develops human cell programming technology that produces consistent, scalable human cells for research, drug discovery and toxicology, helping pharmaceutical and biotech companies reduce reliance on animal testing and improve predictive accuracy.

M&G Investments

- Life Sciences
1(12 months)
mandg.com/investments/gb
Update Information

More venture news

Metaview
30 Sept 2026
Metaview unlocks a £45m Series C led by Insight Partners to automate hiring with sourcing and screening agents
Series CHR
Basecamp Research
23 Sept 2026
Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models
Series CLife Sciences
Cambridge Aerospace
10 Aug 2026
Cambridge Aerospace lands £222m Series C led by DFJ Growth for low-cost drone interceptor missiles
Series CDefence

M&G Investments: Investment Portfolio & Startup News

Investment Portfolio

bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology

More venture news

Metaview unlocks a £45m Series C led by Insight Partners to automate hiring with sourcing and screening agents

Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models

Cambridge Aerospace lands £222m Series C led by DFJ Growth for low-cost drone interceptor missiles